Voyageur Pharmaceuticals (CVE:VM) Shares Down 31.3% – Here’s Why

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM) were down 31.3% during trading on Thursday . The stock traded as low as C$0.14 and last traded at C$0.17. Approximately 1,643,425 shares traded hands during mid-day trading, an increase of 198% from the average daily volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Performance

The firm’s 50-day moving average is C$0.10 and its 200 day moving average is C$0.07. The stock has a market cap of C$23.01 million, a PE ratio of -16.50 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.